Correlation Between Passage Bio and Pmv Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Passage Bio and Pmv Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Passage Bio and Pmv Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Passage Bio and Pmv Pharmaceuticals, you can compare the effects of market volatilities on Passage Bio and Pmv Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Passage Bio with a short position of Pmv Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Passage Bio and Pmv Pharmaceuticals.
Diversification Opportunities for Passage Bio and Pmv Pharmaceuticals
-0.24 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Passage and Pmv is -0.24. Overlapping area represents the amount of risk that can be diversified away by holding Passage Bio and Pmv Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pmv Pharmaceuticals and Passage Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Passage Bio are associated (or correlated) with Pmv Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pmv Pharmaceuticals has no effect on the direction of Passage Bio i.e., Passage Bio and Pmv Pharmaceuticals go up and down completely randomly.
Pair Corralation between Passage Bio and Pmv Pharmaceuticals
Given the investment horizon of 90 days Passage Bio is expected to generate 3.29 times more return on investment than Pmv Pharmaceuticals. However, Passage Bio is 3.29 times more volatile than Pmv Pharmaceuticals. It trades about 0.1 of its potential returns per unit of risk. Pmv Pharmaceuticals is currently generating about -0.02 per unit of risk. If you would invest 66.00 in Passage Bio on August 29, 2024 and sell it today you would earn a total of 9.00 from holding Passage Bio or generate 13.64% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 95.65% |
| Values | Daily Returns |
Passage Bio vs. Pmv Pharmaceuticals
Performance |
| Timeline |
| Passage Bio |
| Pmv Pharmaceuticals |
Passage Bio and Pmv Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Passage Bio and Pmv Pharmaceuticals
The main advantage of trading using opposite Passage Bio and Pmv Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Passage Bio position performs unexpectedly, Pmv Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pmv Pharmaceuticals will offset losses from the drop in Pmv Pharmaceuticals' long position.| Passage Bio vs. Bright Minds Biosciences | Passage Bio vs. HP Inc | Passage Bio vs. Intel | Passage Bio vs. Chevron Corp |
| Pmv Pharmaceuticals vs. Bright Minds Biosciences | Pmv Pharmaceuticals vs. HP Inc | Pmv Pharmaceuticals vs. Intel | Pmv Pharmaceuticals vs. Chevron Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Complementary Tools
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |